<DOC>
	<DOCNO>NCT02450175</DOCNO>
	<brief_summary>The purpose research study understand platelet blood become active cancer specially advanced stage cancer , future investigator want see reduce platelet activity improve survival advanced cancer .</brief_summary>
	<brief_title>Etiology Platelet-Cancer Metastatic Pathway - A Study Inflammatory Markers , Platelet Characteristics Metastatic Surrogates Cancer Patients Controls</brief_title>
	<detailed_description>Hypotheses propose study Platelet reactivity measure percentage aggregation response agonists ADP increase patient metastatic cancer compare age sex ethnicity match control . Platelet activation measure release cytokine vasoactive substance VEGF , TGF-beta , PDGF increase patient metastatic cancer compare age sex ethnicity match control . Study Design : Single center match case control design ; match variable age , sex ethnicity Inclusion Criteria Cases : 25 adult patient ( &gt; 18 year old ) form metastatic advanced stage ( TNM stage III equivalent ) solid adenocarcinoma include breast , colon , lung cancer eligible inclusion study restriction relate previous chemotherapy , radiotherapy , biological therapy surgical management time enrollment past. , although prefer recruit prior initiate chemotherapy . Controls : 25 patient select base age ( +/- 5 year ) , sex ethnicity match outpatient medicine Clinic Sinai hospital , well Sinai community care clinic . Exclusion Criteria : Thrombocytopenia , define platelet count &lt; 100,000 time recruitment last available laboratory data History know bleed disorder know platelet dysfunction Patients antiplatelet treatment anticoagulant therapy time enrollment 10 day prior test CKD stage IV great</detailed_description>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Cases : 25 adult patient ( &gt; 18 year old ) form metastatic advanced stage ( TNM stage III equivalent ) solid adenocarcinoma include breast , colon , lung cancer eligible inclusion study restriction relate previous chemotherapy , radiotherapy , biological therapy surgical management time enrollment past. , although prefer recruit prior initiate chemotherapy . Controls : 25 patient select base age ( +/ 5 year ) , sex ethnicity match outpatient medicine Clinic Sinai hospital , well Sinai community care clinic . Thrombocytopenia , define platelet count &lt; 100,000 time recruitment last available laboratory data History know bleed disorder know platelet dysfunction Patients antiplatelet treatment anticoagulant therapy time enrollment 10 day prior test CKD stage IV great</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Platelet Activation</keyword>
	<keyword>metastasis</keyword>
</DOC>